Work Here?
Work Here?
Work Here?
Dyno Therapeutics focuses on improving gene therapy by creating Adeno-associated virus (AAV) vectors, which are essential for delivering genetic material into cells. Their technology utilizes Artificial Intelligence to design and optimize these vectors, enhancing the effectiveness of gene therapies. The company collaborates with major pharmaceutical and biotech firms, such as Astellas, Roche, and Novartis, to develop treatments for various diseases affecting muscles, the central nervous system, liver, and eyes. Unlike many competitors, Dyno leverages its proprietary AI technology to create tailored AAV vectors, which sets it apart in the biotech field. The goal of Dyno Therapeutics is to advance gene therapy solutions that can significantly improve patient outcomes.
Company Stage
Series A
Employees
51-200
Industries
Hardware, AI & Machine Learning, Biotechnology, Healthcare
Total Funding
$109M
Headquarters
N/A
Founded
2018
Find jobs on Simplify and start your career today